Approval · Notice of Compliance 22636 · 2019
CALDOLOR: Notice of Compliance 22636
Issued September 11, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22636
- Date
- September 11, 2019
- Company
- Cumberland Pharmaceuticals IncNashville, Tennessee, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in product ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CALDOLOR | 02376857 | Dormant |
Medicinal ingredients
- IBUPROFEN 100 MG per ML